KPET KPET Ultra Paceline Corp
Blank Checks · NYSE · SEC CIK 2095297 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 |
|---|---|---|---|
| Income statement | |||
| Revenue | — | — | — |
| SG&A expense | $163,316 | $395,115 | $40,043 |
| Operating income | -$163,316 | -$395,115 | — |
| Net income | $1.95M | $1.62M | -$40,043 |
| EPS (basic) | — | — | -0.01 |
| EPS (diluted) | — | — | -0.01 |
| Weighted avg. shares (diluted) | — | — | 5.00M |
| Balance sheet | |||
| Cash & equivalents | $1.22M | $1.37M | $1.76M |
| Current assets | $1.31M | $1.45M | $1.86M |
| Total assets | $235.17M | $233.33M | $2.65M |
| Current liabilities | $18,343 | $141,244 | $2.73M |
| Total liabilities | $12.83M | $12.94M | $2.73M |
| Shareholders' equity | -$11.23M | -$11.07M | -$77,912 |
| Cash flow statement | |||
| Operating cash flow | -$194,774 | -$249,442 | -$130,425 |
| Investing cash flow | $125,000 | -$229.62M | -$250,000 |
| Financing cash flow | -$85,000 | $229.49M | $2.14M |
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.